Anti-IL-13 Antibody (H2L6) is a humanized monoclonal antibody specifically targeting human interleukin-13 (IL-13). The compound binds to IL-13 with high affinity, effectively blocking its interaction with the receptor complex (IL-13Ra1 and IL-4Ra), thereby inhibiting downstream signaling. As IL-13 is a key driver of Th2-mediated immune responses, H2L6 is widely utilized in preclinical research for asthma, atopic dermatitis, and other allergic or inflammatory disorders.
Target:
IL Receptor
T9901A-1317
* VAT and and shipping costs not included. Errors and price changes excepted
